This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, charitable and public sectors to anticipate and address challenges of translating science into health.
Read more about our strategic direction
Priority area 1
Support the implementation of emerging health technologies for public benefit
Emerging biomedical technologies
Regulation, governance and ethics
Priority area 2
Optimise the use of data to deliver better population health
Climate change and human genomics
